NCT01520103 Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT01497860 Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas Status COMPLETED Phase PHASE2
NCT01441596 Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases Status COMPLETED Phase PHASE2
NCT01439191 Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01305941 A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2
NCT01254136 Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01242449 Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01209520 Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy Status COMPLETED Phase NA
NCT01196078 A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE4
NCT01137994 A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer Status WITHDRAWN Phase PHASE2
NCT01125566 LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment Status COMPLETED Phase PHASE3
NCT01109524 Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01060514 Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer Status TERMINATED Phase PHASE1
NCT01038037 First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01020864 Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer Status WITHDRAWN Phase PHASE2
NCT01007942 Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00958724 Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors Status COMPLETED Phase PHASE1